BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups, focusing on improving human health and enhancing quality of life. They are an evergreen fund with a long-term investment perspective and have successfully attracted over $4.2 billion in external capital to support the growth of their portfolio companies.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions